Patents by Inventor Charles Gerald Connor

Charles Gerald Connor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT FOR DRY EYE
    Publication number: 20210008079
    Abstract: The present invention comprises a composition and method treating eye diseases using a composition having a therapeutically effective amount of a progestagen and a pharmaceutically acceptable carrier, wherein the composition is applied to the palpebral part of the eye and/or ocular surface.
    Type: Application
    Filed: February 18, 2020
    Publication date: January 14, 2021
    Inventors: Charles Gerald CONNOR, Charles L. HAINE
  • Treatment for dry eye
    Publication number: 20140113889
    Abstract: The present invention comprises a composition and method treating eye diseases using a composition having a therapeutically effective amount of a progestagen and a pharmaceutically acceptable carrier, wherein the composition is applied to the palpebral part of the eye and/or ocular surface.
    Type: Application
    Filed: December 23, 2013
    Publication date: April 24, 2014
    Applicant: Rhodes Pharmaceuticals, LP
    Inventors: Charles Gerald Connor, Charles L. Haine
  • Treatment for dry eye
    Publication number: 20080132475
    Abstract: The present invention comprises a composition and method treating eye diseases using a composition having a therapeutically effective amount of a progestagen and a pharmaceutically acceptable carrier, wherein the composition is applied to the palpebral part of the eye and/or ocular surface.
    Type: Application
    Filed: December 5, 2006
    Publication date: June 5, 2008
    Inventors: Charles Gerald Connor, Charles L. Haine
  • Method to use transdermal administration of androgens to the adnexa of the eye
    Patent number: 6659985
    Abstract: This invention relates to a method for treating dry eye or increasing contact lens wear time through the transdermal delivery of androgenic hormones to the adnexa of the eye. More specifically, an androgenic hormone such as testosterone or dehydroepiandrosterone is solubilized in pharmaceutically effective carrier such as a facial cream or gel. The androgenic hormone in a pharmaceutically effective carrier is applied to the adnexa of the eye, which is the tissue adjacent to and surrounding the eyeball.
    Type: Grant
    Filed: January 30, 2002
    Date of Patent: December 9, 2003
    Assignee: Southern College of Optometry
    Inventor: Charles Gerald Connor
  • Method to use transdermal administration of androgens to the adnexa of the eye
    Publication number: 20030144635
    Abstract: This invention relates to a method for treating dry eye or increasing contact lens wear time through the transdermal delivery of androgenic hormones to the adnexa of the eye. More specifically, an androgenic hormone such as testosterone or dehydroepiandrosterone is solubilized in pharmaceutically effective carrier such as a facial cream or gel. The androgenic hormone in a pharmaceutically effective carrier is applied to the adnexa of the eye, which is the tissue adjacent to and surrounding the eyeball.
    Type: Application
    Filed: January 30, 2002
    Publication date: July 31, 2003
    Inventor: Charles Gerald Connor